Bank of New York Mellon »

Candel Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-06-30 $338k 54k 6.20

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Taiwan Semiconductor-sp Spon (TSM)

View all positions for Bank of New York Mellon

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Bridgeway Capital Management
Citadel Advisors
Mml Investors Services
Susquehanna International
HB Wealth Management
Bank of New York Mellon
Bank of America Corporation
Charles Schwab Investment Management
Cubist Systematic Strategies

View all funds holding Candel Therapeutics